Psilocybin — Podcast — Psychedelic Medicine Podcast

Psilocybin for Anorexia Nervosa with Stephanie Knatz Peck, PhD

In this episode of the Psychedelic Medicine Podcast, Stephanie Knatz Peck, PhD joins to discuss the research on psilocybin for anorexia nervosa. Dr. Stephanie Knatz Peck is a clinical psychologist and Associate Clinical Professor at the University of California, San Diego with an expertise in eating disorders. She conducts clinical research on novel treatments for eating disorders and has been involved with clinical research evaluating psychedelics across a variety of mental health indications in the capacity of researcher and therapist. She also published the first ever report on a clinical study evaluating psilocybin for anorexia nervosa.

Plant Medicine.orgDecember 13, 2023Psilocybin

Managing Medical Risk in Patients Seeking Psilocybin Therapy with Reid Robison, MD, MBA

In this episode of the Psychedelic Medicine Podcast, Dr. Reid Robison joins to discuss managing medical risk in patients seeking psilocybin therapy. Dr. Robison is a board-certified psychiatrist and Chief Clinical Officer at Numinus, overseeing the company's psychedelic and mental health services across the US and Canada. He has led over 200 clinical trials in neuropsychiatry, including the MAPS-sponsored MDMA-assisted therapy for eating disorders study, and several other psychedelic studies with psilocybin, LSD and DMT.

Plant Medicine.orgJuly 5, 2023Psilocybin

Microdosing and the Placebo Effect with Balázs Szigeti, PhD

In this episode of the Psychedelic Medicine Podcast, Balázs Szigeti, PhD, joins to discuss his research on the intersection of microdosing psychedelics and the placebo effect. Dr. Szigeti studied physics at Imperial College, after which he earned a PhD in computational neuroscience from the University of Edinburgh. He has worked as a biomedical software engineer at the Icahn Genomics Institute and he has conducted the largest placebo-controlled study on psychedelics to date. In his research, Dr. Szigeti uses novel statistical and experimental techniques to explore the intersection of psychedelics and placebo effects.

Plant Medicine.orgJune 30, 2022lsd, Psilocybin

Psilocin vs. Psilocybin: Differences & Potential Clinical Uses with Josh Woolley, MD, PhD

In this episode of the Plant Medicine Podcast, Dr. Josh Woolley joins to discuss the differences between psilocin and psilocybin, and to share upcoming clinical research which will further clarify the safety profiles, subjective effects, and clinical uses of these psychedelic substances. Dr. Woolley is an Associate Professor in Residence in the Department of Psychiatry and Behavioral Sciences at the University of California, San Francisco (UCSF) as well as a staff psychiatrist in Mental Health at the San Francisco Veterans Affairs Medical Center (SFVAMC). He is Board Certified in Psychiatry by the American Board of Psychiatry and Neurology. He is the Director of the Bonding and Attunement in Neuropsychiatric Disorders (BAND) lab at UCSF that focuses on understanding and treating social deficits in neuropsychiatric disorders including schizophrenia, substance use disorders, and mood disorders. He is also the Director of the Translational Psychedelic Research (TrPR) Program at UCSF, which brings together scientists and care providers across disciplines to understand how psilocybin, LSD, ketamine, MDMA, and related compounds impact the brain and other organ systems.

Plant Medicine.orgDecember 1, 2021Psilocybin

The Latest Research on Psilocybin for Depression with Matthew Johnson, PhD

In this episode of the Plant Medicine Podcast, Matt Johnson, PhD joins to discuss the latest research of psilocybin as a treatment for depression. Dr. Johnson is the associate director at the Center for Psychedelic and Consciousness Research at Johns Hopkins University, where he also works as a professor of psychiatry and behavioral sciences. He has published widely in the field of psychedelic science and has guided over one hundred psychedelic experiences. In 2019 Dr. Johnson was the president of the psychopharmacology division of the American Psychological Association, and he currently serves as the president of the International Society for the Research on Psychedelics.

Plant Medicine.orgSeptember 2, 2021Psilocybin

The Psychedelic Election Winners with Noah Potter

This week's episode of the Plant Medicine Podcast offers an overview of the three psychedelic ballot measures which passed this past election cycle. Attorney Noah Potter joins to share his expertise in psychedelic law and describes the details of Initiative 81 in DC and Measures 109 and 110 in Oregon. Noah is a New York-based attorney, media commentator, and psychedelic legalization strategist who has been discussing topics of psychedelic law on his blog for the past decade.

Plant Medicine.orgNovember 11, 2020Psilocybin

Microdosing Q&A with James Fadiman

In this episode, Dr. Fadiman answers listener-submitted questions regarding microdosing psilocybin and LSD. He discussed dosing recommendations, tolerance, microdosing's general effects on healthy normals, and its specific effects on a number of conditions, ranging from depression to PMS. He also covered a variety of additional areas where people benefit from microdosing, including academic performance and athletics.

Plant Medicine.orgAugust 19, 2020lsd, Psilocybin

How YOU Can Participate in The New Psilocybin Study from Unlimited Sciences and Johns Hopkins

Del Jolly is cofounder and director of Unlimited Sciences, a psychedelic research non-profit. He was the outreach director for the Decriminalize Denver team that passed the historic legislation which decriminalized psilocybin in Denver, leading to a nation-wide movement. Before that, he worked for Charlotte’s Web CBD in business development and is on the board of community advisors for the Realm of Caring, a cannabis non-profit.

Plant Medicine.orgJuly 22, 2020Psilocybin

Decriminalization of Psilocybin with Attorney Sean McAllister

In today’s episode, Sean McAllister explains the history of psilocybin’s legality in the United States and what its legal status is today. Sean is an attorney working for decriminalization efforts in California and Colorado. He was general counsel for the decriminalization movement in Denver and is a key figure in legalization efforts in California.

Plant Medicine.orgDecember 4, 2019Psilocybin

Psilocybin Patient Experience with Dr. Lynn Marie Morski

Today I’m sharing with you the psilocybin patient experience. Disclaimer: I’m not coming to you as a doctor, lawyer, or researcher in this episode, but simply as someone who has experienced psilocybin and is talking about the experience for educational purposes.

Plant Medicine.orgNovember 13, 2019Psilocybin

Psilocybin Scientific Research with Dr. Albert Garcia-Romeu

Today’s episode is the first in our series focusing on psilocybin’s potential uses as medicine. You are going to hear from one of the premier researchers into this drug, how he runs his studies, and what he has discovered concerning its effects and uses as a medicine.

Plant Medicine.orgNovember 6, 2019Psilocybin